Analytical results that you can depend on are crucial to success, especially in a regulated environment. For example, immunoassays that consistently deliver reliable data with high accuracy and precision are worth their weight in gold. ELISA has been the standard for immunoassays, but this situation is changing. We present here two case studies that show how a move from ELISA to Gyrolab™ assays is helping your colleagues to improve their results and lab workflows.
Case study #1: High performance analysis of Host Cell Protein impurities in bioprocess samples
Case study #2: Fit-for-purpose analysis of therapeutic antibodies in clinical samples
Downloading literature requires a simple, one-time registration